Study Supports the Use of Repetitive TMS for Treatment Resistant Depression
A study in France has found that 1 in 4 individuals may achieve remission for treatment resistant depression with repetitive TMS.
New Study Regarding Improvement of ADHD Detection
A researcher from a University at Buffalo is currently studying how brian connectivity, specific communication among different brain regions, are able to fulfill the role as a bio-marker for attention deficit hyperactivity disorder (ADHD). ADHD is commonly diagnosed psychological disorder for school-adged children.
Brain connectivity of ADHD may be a more stable diagnosis since a diagnostic "flip-flop" might not be seen. The article talks about how a clinical diagnosis of ADHD in a patient may be difficult to perceive since the patient's behavioral symptoms may be inconsistent during evaluations. This means that the paient can exhibit symptoms that display prominent signs of ADHD one day, but days later those same symptoms may not be present or to the same degree.
To read more about this new study, click here.
You Might Also Enjoy...
List of TMS Devices that Have Been Cleared by the FDA to Treat Major Depression
Here is a list of TMS devices currently cleared by the FDA to treat major depression.
TMS for Parkinson's Disease
Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.
SAINT Protocol Now Cleared by the FDA
Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).
Preliminary Data Shows How TMS May Treat Depressive Symptoms in Patients with Multiple Sclerosis
Read about how Transcranial Magnetic Stimulation (TMS) may help with the depressive symptoms that patients with multiple sclerosis experience.
FDA Clears TMS Use for Obsessive-Compulsion Disorder (OCD)
The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.